Svas Biosana SpAMIL:SVS +0.68%79 Buyback Yield % is 1.72 as of Jul. 12, 2026, which is 85% above its 10-year median of 0.93. GuruFocus rates MIL:SVS with a GF Score™ of 79/100 and a GF Value™ of €9.64 (Fairly Valued). The stock has 3 warning signs investors should review. Among 346 Medical Devices & Instruments companies, Svas Biosana SpA ranks better than 84.97% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Svas Biosana SpA's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:SVS vs ABT, SYK, MDT: Buyback Yield % Comparison
For the Medical Devices subindustry, Svas Biosana SpA's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Svas Biosana SpA Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Svas Biosana SpA's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Svas Biosana SpA's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Svas Biosana SpA (MIL:SVS) has a Buyback Yield % of 1.72 as of Jul. 12, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Svas Biosana SpA and its competitors. This is 85% above median its historical median of 0.93. Over the past decade, Svas Biosana SpA's Buyback Yield % has ranged from 0.49 to 1.91. According to the industry distribution chart, Svas Biosana SpA ranks #52 out of 346 companies in the Medical Devices & Instruments industry, placing it in the top 15%.
Is Svas Biosana SpA's Buyback Yield % too high?
Svas Biosana SpA's current Buyback Yield % of 1.72 is 85% above median its 10-year median of 0.93. Over the past 10 years, this metric has ranged from a low of 0.49 to a high of 1.91. Based on the distribution chart, Svas Biosana SpA ranks #52 out of 346 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Svas Biosana SpA has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Svas Biosana SpA's Buyback Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Svas Biosana SpA ranks #52 out of 346 companies for Buyback Yield %. This places Svas Biosana SpA in the top 15% of its industry — outperforming the majority of peers. Historically, Svas Biosana SpA's own Buyback Yield % has ranged from 0.49 to 1.91 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Svas Biosana SpA and its competitors. Svas Biosana SpA's current Buyback Yield % is 1.72, which is 85% above median its own 10-year median of 0.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Svas Biosana SpA stock overvalued right now?
Based on GuruFocus' analysis, Svas Biosana SpA (MIL:SVS) is currently considered Fairly Valued. The stock's GF Value™ is €9.64, compared to a current price of €8.90 — trading 7.7% below its estimated fair value. The current Buyback Yield % is 1.72, which is 85% above median its 10-year median of 0.93. Svas Biosana SpA's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Svas Biosana SpA (MIL:SVS), the current Buyback Yield % is 1.72 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Svas Biosana SpA (MIL:SVS) Overvalued in 2026?
Based on GuruFocus' analysis, Svas Biosana SpA stock appears to be undervalued.
The current stock price of €8.90 is trading 7.7% below its estimated GF Value™ of €9.64.
GuruFocus considers Svas Biosana SpA to be Fairly Valued.
Key valuation signals for MIL:SVS:
Buyback Yield %: 1.72 (85% above median its 10-year median of 0.93)
GF Value™: €9.64 vs. price of €8.90 (7.7% below fair value)
No single metric tells the full story. See the MIL:SVS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:SVS has been successfully added to your 
